((SL Advertiser)) Boston Scientific has prostate cancer solutions at Valley Urologic Associates. To learn more, go to ...

Boston Scientific Corp. closed $1.60 below its 52-week high ($84.12), which the company achieved on September 13th.

Boston Scientific Corp. closed $0.61 short of its 52-week high ($84.12), which the company reached on September 13th.

Silk Road Medical said in a securities filing that the antitrust waiting period expired Thursday evening, opening the door to ...

Boston Scientific (NYSE: BSX) announced today that it completed its $1.16 billion acquisition of Silk Road Medical ...

Boston Scientific (NYSE: BSX) received FDA approval to expand the indication for its current-generation Ingevity+ pacing ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Boston Scientific (BSX – Research Report), ...

Boston Scientific Corporation (BSX) stock saw a decline, ending the day at $82.52 which represents a decrease of $-0.99 or -1.19% from the prior close of $83.51. The stock opened at $83.33 and touched ...

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of California medical ...

Investors have rewarded BSX stock thanks to the uptick in its sales for its new products and the Watchman line.

Bank of America Securities analyst Travis Steed has maintained their bullish stance on BSX stock, giving a Buy rating on September 5. Travis ...

In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against Morgan ...